Cyclica Inc.

Cyclica is a Toronto-based biotechnology company that leverages biophysics and artificial intelligence (AI) to make drug discovery faster, safer, and cheaper. We enable all scientists in Pharma with an integrated network of technologies, thereby driving drug discovery and revolutionizing a system troubled with attrition and costly failures. Our cloud-based Ligand Express® platform de novo uncovers the polypharmacological profiles of small molecules to provide insight into target identification and mechanism of drug action, lead prioritization, and drug repurposing. We have expanded the value of Ligand Express downstream to examine the impact that genetic differences have on protein structure, and hence gaining insight into structural pharmacogenomics.